- Home
- LSTA vs ENLV Comparison
LSTA vs ENLV Comparison
Compare LSTA & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- ENLV
- Stock Information
- Founded
- LSTA 1980
- ENLV 2005
- Country
- LSTA United States
- ENLV Israel
- Employees
- LSTA N/A
- ENLV N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- ENLV Health Care
- Exchange
- LSTA Nasdaq
- ENLV Nasdaq
- Market Cap
- LSTA 24.2M
- ENLV 25.9M
- IPO Year
- LSTA N/A
- ENLV 1995
- Fundamental
- Price
- LSTA $2.58
- ENLV $1.20
- Analyst Decision
- LSTA Strong Buy
- ENLV Strong Buy
- Analyst Count
- LSTA 1
- ENLV 2
- Target Price
- LSTA $15.00
- ENLV $9.50
- AVG Volume (30 Days)
- LSTA 19.6K
- ENLV 462.9K
- Earning Date
- LSTA 11-12-2024
- ENLV 11-29-2024
- Dividend Yield
- LSTA N/A
- ENLV N/A
- EPS Growth
- LSTA N/A
- ENLV N/A
- EPS
- LSTA N/A
- ENLV N/A
- Revenue
- LSTA N/A
- ENLV N/A
- Revenue This Year
- LSTA N/A
- ENLV N/A
- Revenue Next Year
- LSTA N/A
- ENLV N/A
- P/E Ratio
- LSTA N/A
- ENLV N/A
- Revenue Growth
- LSTA N/A
- ENLV N/A
- 52 Week Low
- LSTA $2.19
- ENLV $0.81
- 52 Week High
- LSTA $3.83
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- LSTA 41.13
- ENLV 50.34
- Support Level
- LSTA $2.48
- ENLV $1.13
- Resistance Level
- LSTA $2.77
- ENLV $1.24
- Average True Range (ATR)
- LSTA 0.19
- ENLV 0.10
- MACD
- LSTA -0.01
- ENLV 0.01
- Stochastic Oscillator
- LSTA 56.52
- ENLV 58.10
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.